Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients with Meniere's disease

Acta Otolaryngol. 2012 Feb;132(2):141-5. doi: 10.3109/00016489.2011.635383. Epub 2011 Dec 27.

Abstract

Conclusion: 3 T MRI after intratympanic injection of gadolinium-based contrast agent (GBCA) is more useful for the diagnosis of endolymphatic hydrops compared with the glycerol test and electrocochleography (ECoG).

Objective: To investigate the relationship between 3 T MRI after intratympanic injection of GBCA, the glycerol test, and ECoG in patients with Meniere's disease (MD).

Methods: A total of 20 patients with MD were evaluated. Diluted gadodiamide (a gadolinium-based contrast agent) was administered to the bilateral tympanic cavity by injection through the tympanic membrane. After 24 h, the endolymphatic hydrops was evaluated by a 3.0 T MR scanner. To investigate cochlear hydrops, the glycerol test and ECoG were carried out in all patients.

Results: A positive result was observed in 11 patients (55%) in the glycerol test and in 12 patients (60%) by ECoG. The incidence of positive findings when evaluating the same patients with both the glycerol test and ECoG increased to 75%. Nineteen of 20 (95%) patients showed positive results for 3 T MRI.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Adult
  • Aged
  • Aged, 80 and over
  • Audiometry, Evoked Response*
  • Audiometry, Pure-Tone
  • Contrast Media
  • Female
  • Gadolinium DTPA
  • Glycerol*
  • Humans
  • Imaging, Three-Dimensional*
  • Injections
  • Magnetic Resonance Imaging / methods*
  • Male
  • Meniere Disease / diagnosis*
  • Middle Aged
  • Young Adult

Substances

  • Contrast Media
  • gadodiamide
  • Gadolinium DTPA
  • Glycerol